Abstract
Proteoglycans are macromolecules expressed on the cell surfaces and in the extracellular matrix of most animal tissues (Annu Rev Biochem 68:729–777, 1999; Int Rev Cell Mol Biol 276:105–159, 2009). Heparan sulfate proteoglycans (HSPGs) are essential for animal development and homeostasis, and are involved in various pathological processes. The functions of HSPGs are largely exerted through interaction of the heparan sulfate (HS) side chains with different types of ligands, including diverse molecules such as cytokines, enzymes, and pathogens. One of the important roles of cell surface HSPGs is to mediate cytokine-induced cell signaling through interaction with growth factors (GFs) and their cognate receptors. A selective dependence of GFs for different structural features of HS has been demonstrated by applying cell models that are mutated variously in HS structure due to deficiency in enzymes involved in the biosynthesis of HS chains.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Bernfield, M., Götte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., and Lincecum, J., and Zako, M. (1999) Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68, 729–777.
Lindahl, U. and Li, J.-P. (2009) Interactions between heparan sulfate and proteins-design and functional implications. Int Rev Cell Mol Biol 276, 105–159.
Jastrebova, N., Vanwildemeersch, M., Lindahl, U., and Spillmann, D. (2010) Heparan sulfate domain organization and sulfation modulate FGF2 induced cell signaling. J Biol Chem 27, 26842–26851.
Rapraeger, A. C. (1995) In the clutches of proteoglycans: how does heparan sulfate regulate FGF binding? Chem Biol. 2, 645–649.
Yayon, A., Klagsbrun, M., Esko, J. D., et al (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841–848.
Mohammadi, M., Olsen, S. K., and Ibrahimi, O. A. (2005) Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev 16, 107–137.
Schlessinger, J., Plotnikov, A. N., Ibrahimi, O. A., Eliseenkova, A. V., Yeh, B. K., Yayon, A., et al (2000) Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell 6, 743–750.
Pellegrini, L., Burke, D. F., Von Delft, F., Mulloy, B., and Blundell, T. L. (2000) Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature 407, 1029–1034.
Takazaki, R., Shishido, Y., Iwamoto, R., and Mekada, E. (2004) Suppression of the biological activities of the epidermal growth factor (EGF)-like domain by the heparin-binding domain of heparin-binding EGF-like Growth Factor. J Biol Chem. 279, 47335–47343.
Barnett, M. W., Fisher, C. E., Perona-Wright, G., and Davies, J. A. (2002) Signalling by glial cell line-derived neurotrophic factor (GDNF) requires heparan sulphate glycosaminoglycan. J Cell Sci. 115, 4495–4503.
Davies, J. A., Yates, E. A., and Turnbull, J. E. (2003) Structural determinants of heparan sulphate modulation of GDNF signalling. Growth Factors 21, 109–119.
Kemp, L. E., Mulloy, B., and Gherardi, E. (2006) Signalling by HGF/SF and Met: the role of heparan sulphate co-receptors. Biochem Soc Trans. 34, 414–417.
Lustig, F., Hoebeke, J., Östergren-Lunden, G., Velge-Roussel, F., Bondjers, G., Olsson, U., et al (1996) Alternative splicing determines the binding of platelet-derived growth factor (PDGF-AA) to glycosaminoglycans. Biochemistry 17, 12077–12085.
Carrasco, H., Olivares, G. H., Faunes, F., Oliva, C., and Larraín, J. (2005) Heparan sulfate proteoglycans exert positive and negative effects in Shh activity. J Cell Biochem 96, 831–838.
Ito, N. and Claesson-Welsh, L. (1999) Dual effects of heparin on VEGF binding to VEGF receptor-1 and transduction of biological responses. Angiogenesis 3, 159–166.
Selleck, S. B. (2006) Signaling from across the way: transactivation of VEGF receptors by HSPGs. Mol Cell 22, 431–432.
Rider, C. C. (2006) Heparin/heparan sulphate binding in the TGF-beta cytokine superfamily. Biochem Soc Trans 34, 458–460.
Tsuda, M., Kamimura, K., Nakato, H., Archer, M., Staatz, W., Fox, B., Humphrey, M., et al (1999) The cell-surface proteoglycan Dally regulates Wingless signalling in Drosophila. Nature 400, 276–280.
Kikuchi, A., Yamamoto, H., and Sato, A. (2009) Selective activation mechanisms of Wnt signaling pathways. Trends Cell Biol 19, 119–129.
Cuellar, K., Chuong, H., Hubbell, S. M., and Hinsdale, M. E. (2007) Biosynthesis of chondroitin and heparan sulfate in Chinese hamster ovary cells depends on xylosyltransferase II. J Biol Chem. 282, 5195–5200.
Fransson, L-Å., Silverberg, I., and Carlstedt, I. (1985) Structure of the heparan sulfate-protein linkage region. Demonstration of the sequence galactosyl-galactosyl-xylose-2-phosphate. J Biol Chem. 260, 14722–14726.
Lin, X., Wei, G., Shi, Z., Dryer, L., Esko, J. D., Wells, D. E., and Matzuk, M. M. (2000) Disruption of gastrulation and heparan sulfate biosynthesis in EXT1- deficient mice. Dev Biol. 224, 299–311.
Stickens, D., Zak, B. M., Rougier, N., Esko, J. D., and Werb, Z. (2005) Mice deficient in Ext2 lack heparan sulfate and develop exostoses. Development 132, 5055–5068.
Ringvall, M., Ledin, J., Holmborn, K., van Kuppevelt, T., Ellin, F., Eriksson, I., et al (2000) Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deace-tylase/N-sulfotransferase-1. J Biol Chem. 275, 25926–25930.
Forsberg, E., Pejler, G., Ringvall, M., Lunderius, C., Tomasini-Johansson, B., Kusche-Gullberg, M., et al (1999) Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature 400, 773–776.
Pallerla, S. R., Lawrence, R., Lewejohann, L., Pan, Y., Fischer, T., Schlomann, U., et al (2008) Altered heparan sulfate structure in mice with deleted NDST3 gene function. J Biol Chem 283, 16885–16894.
Li, J. P., Gong, F., Hagner-Mcwhirter, Å., Forsberg, E., Abrink, M., Kisilevsky, R., et al (2003) Targeted disruption of murine glucuronyl C5-epimerase gene results in heparan sulfate lacking L-iduronic acid and in neonatal lethality. J Biol Chem. 278, 28363–28366.
Jia, J., Maccarana, M., Zhang, X., Bespalov, M., Lindahl, U., and Li, J. P. (2009) Lack of L-iduronic acid in heparan sulfate affects interaction with growth factors and cell signaling. J Biol Chem. 284, 15942–15950.
Bullock, S. L., Fletcher, J. M., Beddington, R. S., and Wilson, V. A. (1998) Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase. Genes Dev. 12, 1894–1906.
Smeds, E., Habuchi, H., Do, A. T., Habuchi, H., Kimata, K., Lindahl, U., and Kusche-Gullberg, M. (2003) Substrate specificities of mouse heparan sulphate glucosaminyl 6-O-sulphotransferases. Biochem J. 372: 371–380.
Habuchi, H., Nagai, N., Sugaya, N., Atsumi, F., Stevens, R. L., and Kimata, K. (2007) Mice deficient in heparan sulfate 6-O-sulfotransferase-1 exhibit defective heparan sulfate biosynthesis, abnormal placentation, and late embryonic lethality. J Biol Chem. 282, 15578–15588.
Ai, X., Kitazawa, T., Do, A. T., Kusche-Gullberg, M., Labosky, P. A., and Emerson, C. P. Jr. (2007) SULF1 and SULF2 regulate heparan sulfate-mediated GDNF signaling for esophageal innervation. Development 134, 3327–3338.
Lum, D. H., Tan, J., Rosen, S. D., and Werb, Z. (2007) Gene trap disruption of the mouse heparan sulfate 6-O-endosulfatase gene, Sulf2. Mol Cell Biol. 27, 678–688.
Rosen, S. D. and Lemjabbar-Alaoui, H. (2010) Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate. Expert Opin Ther Targets 14, 935–949.
Zcharia, E., Metzger, S., Chajek-Shaul, T., Aingorn, H., Elkin, M., Friedmann, Y., et al (2004) Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior. FASEB J 18, 252–263.
Escobar Galvis, M. L., Jia, J., Zhang, X., Jastrebova, N., Spillmann, D., Gottfridsson, E., et al (2007) Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate. Nat Chem Biol 3, 773–778.
Zcharia, E., Jia, J., Zhang, X., Baraz, L., Lindahl, U., Peretz, T., et al (2009) Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinases. PLoS ONE 4, e5181.
Baldwin, R. J., Ten Dam, G. B., Van Kuppevelt, T. H., et al (2008) A developmentally regulated heparan sulfate epitope defines a subpopulation with increased blood potential during mesodermal differentiation. Stem Cells 26, 3108–3118.
Kraushaar, D. C., Yamaguchi, Y., and Wang, L. (2010) Heparan sulfate is required for embryonic stem cells to exit from self-renewal. J Biol Chem. 285: 5907–5916.
Lanner, F., Lee, K. L., Sohl, M., Holmborn, K., Yang, H., Wilbertz, J., et al (2010) Heparan sulfation-dependent fibroblast growth factor signaling maintains embryonic stem cells primed for differentiation in a heterogeneous state. Stem Cells 28, 191–200.
Sun, H. and Taneja, R. (2007) Analysis of transformation and tumorigenicity using mouse embryonic fibroblast cells. Methods Mol Biol. 383, 303–310.
Yamada, S., Busse, M., Ueno, M., Kelly, O. G., Skarnes, W. C., Sugahara, K., and Kusche-Gullberg, M. (2004) Embryonic fibroblasts with a gene trap mutation in Ext1 produce short heparan sulfate chains. J Biol Chem. 279, 32134–32141.
Osterholm, C., Barczyk, M. M., Busse, M., Grønning, M., Reed, R. K., and Kusche-Gullberg, M. (2009) Mutation in the heparan sulfate biosynthesis enzyme EXT1 influences growth factor signaling and fibroblast interactions with the extracellular matrix. J Biol Chem. 284, 34935–34943.
Zhu, W., Wang, L., Yang, Y., Jia, J., Fu, S., Feng, Y., et al (2010) Interaction of E2 glycoprotein with heparan sulfate is crucial for cellular infection of Sindbis virus. PLoS ONE 5, e9656.
Abramsson, A., Kurup, S., Busse, M., Yamada, S., Lindblom, P., Schallmeiner, E., et al (2007) Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development. Genes Dev. 21, 316–331.
Merry, C. L. R., Bullock, S. L., Swan, D. C., Backen, A. C., Lyon, M., Beddington, R. S., et al (2001) The molecular phenotype of heparan sulfate in the Hs2st−/− mutant mouse. J Biol Chem. 276, 35429–35434.
Sugaya, N., Habuchi, H., Nagai, N., Ashikari-Hada, S., and Kimata, K. (2008) 6-O-sulfation of heparan sulfate differentially regulates various fibroblast growth factor-dependent signalings in culture. J Biol Chem. 283, 10366–10376.
Lamanna, W. C., Frese, M. A., Balleininger, M., and Dierks, T. (2008) Sulf loss influences N-, 2-O-, and 6-O-sulfation of multiple heparan sulfate proteoglycans and modulates fibroblast growth factor signaling. J Biol Chem. 283, 27724–27735.
Esko, J. D., Stewart, T. E., and Taylor, W. H. (1985) Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc Natl Acad Sci USA 82, 3197–3201.
Bai, X., Crawford, B., and Esko, J. D. (2001) Selection of glycosaminoglycan-deficient mutants. Methods Mol Biol. 171, 309–316.
Bakker, H., Oka, T., Ashikov, A., Yadav, A., Berger, M., Rana, N. A., et al (2009) Functional UDP-xylose transport across the endoplasmic reticulum/Golgi membrane in a Chinese hamster ovary cell mutant defective in UDP-xylose synthase. J Biol Chem. 284, 2576–2583.
Lidholt, K., Weinke, J. L., Kiser, C. S., Lugemwa, F. N., Bame, K. J., Cheifetz, S., et al (1992) A single mutation affects both N-acetylglucosaminyltransferase and glucuron-osyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis. Proc Natl Acad Sci USA 89, 2267–2271.
Bame, K. J. and Esko, J. D. (1989) Undersulfated heparan sulfate in a Chinese hamster ovary cell mutant defective in heparan sulfate N-sulfotransferase. J Biol Chem. 264, 8059–8065.
Bai, X. and Esko, J. D. (1996) An animal cell mutant defective in heparan sulfate hexuronic acid 2-O-sulfation. J Biol Chem. 271, 17711–17717.
Bai, X., Crawford, B., and Esko, J. D. (2001) Selection of glycosaminoglycan-deficient mutants. Methods Mol Biol. 171, 309–316.
Friedl, A., Filla, M., and Rapraeger, A. C. (2001) Tissue-specific binding by FGF and FGF receptors to endogenous heparan sulfates. Methods Mol Biol. 171, 535–546.
Acknowledgment
The authors are supported by grants from the Swedish Research Council (K2009-67X-21128-01-3), the Swedish Cancer Found-ation (09 0717 and 09 0762), and Polysackaridforskning AB (Uppsala).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Li, Jp., Spillmann, D. (2012). Heparan Sulfate Proteoglycans as Multifunctional Cell Regulators: Cell Surface Receptors. In: Rédini, F. (eds) Proteoglycans. Methods in Molecular Biology, vol 836. Humana Press. https://doi.org/10.1007/978-1-61779-498-8_16
Download citation
DOI: https://doi.org/10.1007/978-1-61779-498-8_16
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-497-1
Online ISBN: 978-1-61779-498-8
eBook Packages: Springer Protocols